The Use of Desmopressin (DDAVP) in Nocturna Urinary Frequency in the Female
- 1 June 1982
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 54 (3) , 252-255
- https://doi.org/10.1111/j.1464-410x.1982.tb06969.x
Abstract
Patients (25) complaining of nocturia completed a double-blind cross-over trial using desmopressin (DDAVP) and placebo. All had failed to respond to treatment with antispasmodic agents and evening fluid restriction. The drugs were given as a single intranasal dose on retiring. Nocturnal urinary frequency was reduced from a mean of 3.2 episodes to 2.6 with palcebo and 1.9 with DDAVP (0.01 > P > 0.001). Diurnal urinary symptoms were not significantly affected and side effects were minimal. This drug seems to have a place in the treatment of nocturia, where more conventional therapies have failed.This publication has 8 references indexed in Scilit:
- Two new modes of desmopressin (DDAVP) administration.BMJ, 1980
- Assessment of renal concentrating ability.BMJ, 1979
- Desmopressin in the Management of Nocturnal Enuresis in Children: A Double-Blind StudyPediatrics, 1978
- DDAVP IN CHILDHOOD NOCTURNAL ENURESISActa Paediatrica, 1978
- 1-Deamino-8-d-arginine vasopressin in the treatment of central diabetes insipidus in childhoodThe Journal of Pediatrics, 1978
- Desmopressin urine concentration test.BMJ, 1978
- Vasopressin Analogue DDAVP in Diabetes Insipidus: Clinical and Laboratory StudiesBMJ, 1973